Peer coaching may ease distress for young women facing breast cancer risk

NCT ID NCT04248257

Completed Knowledge-focused Sponsor: Georgetown University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a 3-session peer coaching program over the phone could help young women (ages 21–30) who have a family history of BRCA mutations. The goal was to see if it reduces cancer-related distress and helps them make informed decisions about genetic counseling. 320 women took part and were followed for a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peer coaching (telephone counseling)
What this could lead to: If successful, this could show that peer support helps young women at high risk for breast cancer feel less distressed and make clearer decisions about genetic counseling.
What could go wrong: This is a completed behavioral study, not a treatment trial. Results may not apply to all women, and the benefits of peer coaching may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary breast ovarian cancer syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER RISK

Contacts and locations

Show contact details

Locations

Dana Farber Cancer Center

Boston, Massachusetts, 02215, United States
Georgetown University

Washington D.C., District of Columbia, 20007, United States
Hackensack University Medical Center

Hackensack, New Jersey, 07061, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10022, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390-9020, United States
University of Washington

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.